Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
adalimumab
biologic therapy
infliximab
optic neuritis
rituximab
tocilizumab
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
11 Aug 2020
11 Aug 2020
Historique:
received:
21
06
2020
revised:
31
07
2020
accepted:
07
08
2020
entrez:
16
8
2020
pubmed:
17
8
2020
medline:
17
8
2020
Statut:
epublish
Résumé
We aimed to assess the efficacy of biologic therapy in refractory non-Multiple Sclerosis (MS) Optic Neuritis (ON), a condition more infrequent, chronic and severe than MS ON. This was an open-label multicenter study of patients with non-MS ON refractory to systemic corticosteroids and at least one conventional immunosuppressive drug. The main outcomes were Best Corrected Visual Acuity (BCVA) and both Macular Thickness (MT) and Retinal Nerve Fiber Layer (RNFL) using Optical Coherence Tomography (OCT). These outcome variables were assessed at baseline, 1 week, and 1, 3, 6 and 12 months after biologic therapy initiation. Remission was defined as the absence of ON symptoms and signs that lasted longer than 24 h, with or without an associated new lesion on magnetic resonance imaging with gadolinium contrast agents for at least 3 months. We studied 19 patients (11 women/8 men; mean age, 34.8 ± 13.9 years). The underlying diseases were Bechet's disease (
Identifiants
pubmed: 32796717
pii: jcm9082608
doi: 10.3390/jcm9082608
pmc: PMC7464396
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Neurology. 2014 Apr 15;82(15):1302-6
pubmed: 24634453
Eur J Neurol. 2010 Aug;17(8):1019-32
pubmed: 20528913
Semin Arthritis Rheum. 2018 Aug;48(1):22-27
pubmed: 29422324
Curr Neurol Neurosci Rep. 2015 Dec;15(12):76
pubmed: 26467052
Cochrane Database Syst Rev. 2015 Aug 14;(8):CD001430
pubmed: 26273799
Lancet Neurol. 2014 Jan;13(1):83-99
pubmed: 24331795
Dev Med Child Neurol. 2020 Mar;62(3):390-395
pubmed: 31468511
Arch Ophthalmol. 1988 Aug;106(8):1051-3
pubmed: 3041942
J Crohns Colitis. 2016 May;10(5):541-8
pubmed: 26759360
Mult Scler. 2016 Mar;22(3):329-39
pubmed: 26041804
N Engl J Med. 2019 Aug 15;381(7):614-625
pubmed: 31050279
Mult Scler. 2019 Dec;25(14):1907-1914
pubmed: 30417715
Ann Rheum Dis. 2018 Jun;77(6):808-818
pubmed: 29625968
Brain. 2004 Nov;127(Pt 11):2498-505
pubmed: 15342363
Acta Neurol Scand. 1992 Sep;86(3):317-22
pubmed: 1414254
Semin Arthritis Rheum. 2015 Dec;45(3):361-8
pubmed: 26092330
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Ann Rheum Dis. 2019 Jun;78(6):736-745
pubmed: 30926722
Semin Arthritis Rheum. 2019 Aug;49(1):126-135
pubmed: 30655091
Curr Neurol Neurosci Rep. 2017 Apr;17(4):36
pubmed: 28337644
Brain. 2002 Apr;125(Pt 4):812-22
pubmed: 11912114
J Ophthalmic Inflamm Infect. 2012 Sep;2(3):145-7
pubmed: 22271346
Neurology. 2019 Apr 16;92(16):765-767
pubmed: 30894449
Eye Brain. 2016 Oct 26;8:195-202
pubmed: 28539814
Intern Med J. 2011 Apr;41(4):354-7
pubmed: 21507165
J Neuroophthalmol. 2014 Dec;34(4):e12-3
pubmed: 25405666
Medicine (Baltimore). 2016 Jun;95(23):e3550
pubmed: 27281066
Arch Neurol. 2009 Nov;66(11):1373-7
pubmed: 19901169
Clin Exp Rheumatol. 2014 Nov-Dec;32(6):864-8
pubmed: 25288110
Indian J Ophthalmol. 2014 Oct;62(10):982-4
pubmed: 25449930
BMC Neurol. 2019 Mar 6;19(1):36
pubmed: 30841862
Semin Ophthalmol. 2016;31(1-2):117-30
pubmed: 26959137
Clin Exp Rheumatol. 2014 Mar-Apr;32(2):275-84
pubmed: 24321604
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647
pubmed: 28572277
Ophthalmology. 2018 Sep;125(9):1444-1451
pubmed: 29602570
Neurology. 2002 Oct 8;59(7):998-1005
pubmed: 12370452
Mult Scler Relat Disord. 2012 Oct;1(4):180-187
pubmed: 24555176
Ocul Immunol Inflamm. 2017 Jun;25(3):405-412
pubmed: 27003323
Cochrane Database Syst Rev. 2015 Jan 07;1:CD008081
pubmed: 25564068
N Engl J Med. 2019 Nov 28;381(22):2114-2124
pubmed: 31774956
JAMA Neurol. 2017 Jul 1;74(7):847-856
pubmed: 28460032
Ann Neurol. 2016 Feb;79(2):206-16
pubmed: 26537743
Lancet. 2019 Oct 12;394(10206):1352-1363
pubmed: 31495497
Br J Ophthalmol. 2004 May;88(5):673-80
pubmed: 15090422
J Neurol. 2014 Jan;261(1):1-16
pubmed: 24272588
Mayo Clin Proc Innov Qual Outcomes. 2019 Aug 02;3(3):358-375
pubmed: 31485575
Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):13-27
pubmed: 30582516
Cancer Treat Rev. 2005 Oct;31(6):456-73
pubmed: 16054760
Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):137-141
pubmed: 31856941
Arthritis Rheumatol. 2019 Dec;71(12):2081-2089
pubmed: 31237427
JAMA Neurol. 2014 Mar;71(3):324-30
pubmed: 24445513
Ann Rheum Dis. 2016 Sep;75(9):1583-94
pubmed: 27338776
Arch Ophthalmol. 2008 Jul;126(7):994-5
pubmed: 18625951
Surv Ophthalmol. 2019 Nov - Dec;64(6):770-779
pubmed: 31229520
Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):367-74
pubmed: 18547481
Rheumatology (Oxford). 2018 Sep 1;57(9):1525-1532
pubmed: 29126262
Rev Neurol (Paris). 2010 Dec;166(12):978-86
pubmed: 20605617
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S54-7
pubmed: 25005576
Eye Brain. 2012 Mar 13;4:13-25
pubmed: 28539778
Cephalalgia. 1991 May;11(2):69-74
pubmed: 1860133
Pract Neurol. 2007 Apr;7(2):112-5
pubmed: 17430876
Drugs. 2009;69(5):609-32
pubmed: 19368420
Rheumatology (Oxford). 2013 May;52(5):868-74
pubmed: 23287362
Pathophysiology. 2011 Feb;18(1):81-92
pubmed: 20472407
Semin Arthritis Rheum. 2016 Aug;46(1):95-101
pubmed: 27060872
BioDrugs. 2007;21(2):125-32; discussion 133-4
pubmed: 17402796